Nuvectis 製藥公司
US ˙ NasdaqCM ˙ US67080T1088

簡介

本頁面提供了有關 Ron Bentsur 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言，基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是，他們必須透過Form 4向美國證券交易委員會（SEC）報告所有交易。盡管存在這些限制，學術研究表明，內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易，排除了作為10b5-1交易計劃的一部分的交易。然後，對每筆交易在3、6和12個月的表現進行平均，以生成該筆交易最終的表現指標。最終，將所有交易的表現指標進行平均，計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A"，則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易，或者他們進行的交易距離現在太近，無法計算出可靠的表現指標。

更新頻率：每日

查看收益最高的的內幕交易者列表。

查看排名最高的內部人士。
報告內部持倉的公司

SEC文件顯示Ron Bentsur已報告在以下公司擁有持倉或進行了交易：

證券 職位 最新報告的持倉
US:NVCT / Nuvectis Pharma, Inc. Chairman & CEO, Director, 10% Owner 3,675,924
US:XAIR / Beyond Air, Inc. Director 144,736
US:STML / Stemline Therapeutics, Inc. Director 0
US:URGN / UroGen Pharma Ltd. Chief Executive Officer, Director 76,226
US:KERX / Keryx Biopharmaceuticals, Inc. Chief Executive Officer, Director 777,209
如何解讀這些圖表

以下圖表顯示了在Ron Bentsur進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如，如果一筆內部人士交易是在2019年1月1日進行的，該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元，則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%，而從10美元跌至5美元的價格變化將為-50%。

最終，我們將評估內部人士的交易與股價的超額回報（正向或負向）之間的相關性，以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為，我們預期看到（a）購買後的正回報，或者（b）賣出後的負回報。對於情況（a），購買圖表將顯示一系列向上傾斜的曲線，表示每次購買後都有正回報。對於情況（b），賣出圖表將顯示一系列向下傾斜的曲線，表示每次賣出後都有負回報。

然而，僅憑這一點還不足以得出結論。例如，如果公司的股價在多年內呈現非周期性上升，我們會預期所有購買後的圖表都呈現向上傾斜。同樣地，多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下，「購買」圖表顯示正向信號，而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易，以獲得財務優勢。

NVCT / Nuvectis Pharma, Inc.內部人士買入 - 短期收益分析

在這一部分，我們分析了在 NVCT / Nuvectis Pharma, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最高利潤的
天數		 達到最高利潤時的
價格		 最高
淨利 ($)		 最高回報率（%）
2025-11-05 NVCT BENTSUR RON 5,000 5.7200 5,000 5.7200 28,600 190 12.4500 33,650 117.66
2024-12-24 NVCT BENTSUR RON 4,500 4.6500 4,500 4.6500 20,925
2024-11-15 NVCT BENTSUR RON 20,000 4.9200 20,000 4.9200 98,400
2024-05-14 NVCT BENTSUR RON 1,940 6.7400 1,940 6.7400 13,076
2024-05-10 NVCT BENTSUR RON 2,000 6.4000 2,000 6.4000 12,800
2024-03-18 NVCT BENTSUR RON 5,000 10.2900 5,000 10.2900 51,450
2023-10-10 NVCT BENTSUR RON 640 11.0800 640 11.0800 7,091
2023-10-09 NVCT BENTSUR RON 830 11.1900 830 11.1900 9,288
2023-10-06 NVCT BENTSUR RON 250 11.2700 250 11.2700 2,818
2023-10-05 NVCT BENTSUR RON 1,400 11.0900 1,400 11.0900 15,526
2023-10-04 NVCT BENTSUR RON 1,820 10.9500 1,820 10.9500 19,929
2023-08-16 NVCT BENTSUR RON 115 15.1500 115 15.1500 1,742
2023-08-15 NVCT BENTSUR RON 235 14.3400 235 14.3400 3,370
2023-08-11 NVCT BENTSUR RON 180 14.6600 180 14.6600 2,639
2023-08-08 NVCT BENTSUR RON 120 14.8300 120 14.8300 1,780
2023-07-21 NVCT BENTSUR RON 225 14.8500 225 14.8500 3,341
2023-07-20 NVCT BENTSUR RON 110 15.0600 110 15.0600 1,657
2023-07-19 NVCT BENTSUR RON 200 14.3300 200 14.3300 2,866
2023-07-14 NVCT BENTSUR RON 150 15.0300 150 15.0300 2,254
2023-07-07 NVCT BENTSUR RON 110 16.1900 110 16.1900 1,781
2023-07-06 NVCT BENTSUR RON 320 14.8800 320 14.8800 4,762
2023-06-26 NVCT BENTSUR RON 750 16.5000 750 16.5000 12,375
2023-06-21 NVCT BENTSUR RON 500 17.8800 500 17.8800 8,940
2023-06-08 NVCT BENTSUR RON 120 17.5300 120 17.5300 2,104
2023-06-07 NVCT BENTSUR RON 230 17.4100 230 17.4100 4,004
2023-05-31 NVCT BENTSUR RON 330 17.2800 330 17.2800 5,702
2023-05-24 NVCT BENTSUR RON 200 17.4900 200 17.4900 3,498
2023-05-16 NVCT BENTSUR RON 320 17.0250 320 17.0250 5,448
2023-03-23 NVCT BENTSUR RON 230 12.1300 230 12.1300 2,790
2023-03-21 NVCT BENTSUR RON 480 12.0800 480 12.0800 5,798
2023-03-15 NVCT BENTSUR RON 480 10.9100 480 10.9100 5,237
2023-03-14 NVCT BENTSUR RON 1,680 10.8500 1,680 10.8500 18,228
2022-11-30 NVCT BENTSUR RON 150 7.4500 150 7.4500 1,118
2022-11-29 NVCT BENTSUR RON 150 7.4500 150 7.4500 1,118
2022-11-28 NVCT BENTSUR RON 150 7.4000 150 7.4000 1,110
2022-11-25 NVCT BENTSUR RON 150 7.3800 150 7.3800 1,107
2022-11-18 NVCT BENTSUR RON 500 7.2300 500 7.2300 3,615
2022-11-17 NVCT BENTSUR RON 250 7.2400 250 7.2400 1,810
2022-11-10 NVCT BENTSUR RON 1,000 7.0700 1,000 7.0700 7,070
2022-09-30 NVCT BENTSUR RON 500 7.4600 500 7.4600 3,730
2022-09-28 NVCT BENTSUR RON 500 7.2300 500 7.2300 3,615
2022-09-26 NVCT BENTSUR RON 500 7.6900 500 7.6900 3,845
2022-09-23 NVCT BENTSUR RON 1,000 7.9300 1,000 7.9300 7,930
2022-09-02 NVCT BENTSUR RON 1,200 8.3700 1,200 8.3700 10,044
2022-09-01 NVCT BENTSUR RON 500 8.1100 500 8.1100 4,055
2022-08-29 NVCT BENTSUR RON 1,000 9.0700 1,000 9.0700 9,070
2022-08-23 NVCT BENTSUR RON 500 9.0000 500 9.0000 4,500
2022-08-19 NVCT BENTSUR RON 5,000 8.9900 5,000 8.9900 44,950
2022-08-18 NVCT BENTSUR RON 14,426 8.5800 14,426 8.5800 123,775
2022-08-11 NVCT BENTSUR RON 19,669 8.4000 19,669 8.4000 165,220
2022-06-29 NVCT BENTSUR RON 3,700 11.6200 3,700 11.6200 42,994
2022-06-28 NVCT BENTSUR RON 300 11.8200 300 11.8200 3,546
2022-06-24 NVCT BENTSUR RON 400 12.1800 400 12.1800 4,872
2022-06-23 NVCT BENTSUR RON 200 11.4000 200 11.4000 2,280
2022-06-22 NVCT BENTSUR RON 100 13.1000 100 13.1000 1,310
2022-05-27 NVCT BENTSUR RON 500 15.7400 500 15.7400 7,870
2022-05-26 NVCT BENTSUR RON 500 15.9000 500 15.9000 7,950
2022-05-20 NVCT BENTSUR RON 1,000 16.2800 1,000 16.2800 16,280
2022-05-19 NVCT BENTSUR RON 200 18.9500 200 18.9500 3,790
2022-05-18 NVCT BENTSUR RON 700 20.6000 700 20.6000 14,420
2022-05-18 NVCT BENTSUR RON 1,000 18.4900 1,000 18.4900 18,490
2022-05-17 NVCT BENTSUR RON 200 19.7700 200 19.7700 3,954
2022-05-17 NVCT BENTSUR RON 110 20.8300 110 20.8300 2,291
2022-05-16 NVCT BENTSUR RON 1,000 19.3200 1,000 19.3200 19,320
2022-05-13 NVCT BENTSUR RON 700 18.1000 700 18.1000 12,670
2022-05-12 NVCT BENTSUR RON 1,100 14.8800 1,100 14.8800 16,368
2022-05-12 NVCT BENTSUR RON 600 16.1200 600 16.1200 9,672
2022-05-12 NVCT BENTSUR RON 10,545 17.2600 10,545 17.2600 182,007
2022-03-28 NVCT BENTSUR RON 4,000 7.0500 4,000 7.0500 28,200
2022-03-17 NVCT BENTSUR RON 7,000 7.6300 7,000 7.6300 53,410
2022-02-14 NVCT BENTSUR RON 8,000 5.8800 8,000 5.8800 47,040
2022-02-10 NVCT BENTSUR RON 8,500 6.3400 8,500 6.3400 53,890
2022-02-07 NVCT BENTSUR RON 14,000 3.9300 14,000 3.9300 55,020
2022-02-07 NVCT BENTSUR RON 6,000 8.2500 6,000 8.2500 49,500
2022-02-04 NVCT BENTSUR RON 200,000 5.0000 200,000 5.0000 1,000,000
2022-02-04 NVCT BENTSUR RON 12,500 3.8900 12,500 3.8900 48,625

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

NVCT / Nuvectis Pharma, Inc. Insider Trades
NVCT / Nuvectis Pharma, Inc.內部人士賣出 - 短期虧損分析

在這一部分，我們分析了在 NVCT / Nuvectis Pharma, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最低利潤的
天數		 達到最低利潤時的
價格		 避免的
最高損失金額($)		 避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

NVCT / Nuvectis Pharma, Inc. Insider Trades
URGN / UroGen Pharma Ltd.內部人士買入 - 短期收益分析

在這一部分，我們分析了在 NVCT / Nuvectis Pharma, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最高利潤的
天數		 達到最高利潤時的
價格		 最高
淨利 ($)		 最高回報率（%）
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

URGN / UroGen Pharma Ltd. Insider Trades
URGN / UroGen Pharma Ltd.內部人士賣出 - 短期虧損分析

在這一部分，我們分析了在 NVCT / Nuvectis Pharma, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最低利潤的
天數		 達到最低利潤時的
價格		 避免的
最高損失金額($)		 避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

URGN / UroGen Pharma Ltd. Insider Trades
XAIR / Beyond Air, Inc.內部人士買入 - 短期收益分析

在這一部分，我們分析了在 NVCT / Nuvectis Pharma, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最高利潤的
天數		 達到最高利潤時的
價格		 最高
淨利 ($)		 最高回報率（%）
2023-03-20 XAIR BENTSUR RON 2,300 6.4800 115 129.6000 14,904 15 6.9200 -14,108 -94.66

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

XAIR / Beyond Air, Inc. Insider Trades
XAIR / Beyond Air, Inc.內部人士賣出 - 短期虧損分析

在這一部分，我們分析了在 NVCT / Nuvectis Pharma, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最低利潤的
天數		 達到最低利潤時的
價格		 避免的
最高損失金額($)		 避免的
最高損失率($)
2022-06-30 XAIR BENTSUR RON 40,000 6.5276 2,000 130.5520 261,104 365 4.2600 -252,584 -96.74
2021-11-24 XAIR BENTSUR RON 31,000 13.4400 1,550 268.8000 416,640
2021-11-24 XAIR BENTSUR RON 6,464 13.9900 323 279.8000 90,431
2021-02-12 XAIR BENTSUR RON 23,419 6.3600 1,171 127.2000 148,945
2021-02-11 XAIR BENTSUR RON 1,500 6.2800 75 125.6000 9,420
2021-01-02 XAIR BENTSUR RON 5,700 5.8900 285 117.8000 33,573

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

XAIR / Beyond Air, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Ron Bentsur 進行的所有內幕交易的完整列表，這些交易已向美國證券交易委員會（SEC）披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化		 每股
股價		 交易
金額		 剩餘
金額
2026-01-09 2026-01-06 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		A - Award 150,000 3,675,924 4.25
2025-11-06 2025-11-05 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 5,000 3,525,924 0.14 5.72 28,600 20,168,285
2025-01-03 2025-01-02 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		A - Award 250,000 3,520,924 7.64
2024-12-26 2024-12-24 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 4,500 3,270,924 0.14 4.65 20,925 15,209,797
2024-11-18 2024-11-15 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 20,000 3,266,424 0.62 4.92 98,400 16,070,806
2024-05-15 2024-05-14 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 1,940 3,246,424 0.06 6.74 13,076 21,880,898
2024-05-13 2024-05-10 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 2,000 3,244,484 0.06 6.40 12,800 20,764,698
2024-03-19 2024-03-18 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 5,000 3,242,484 0.15 10.29 51,450 33,365,160
2023-10-12 2023-10-10 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 640 3,237,484 0.02 11.08 7,091 35,871,323
2023-10-10 2023-10-09 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 830 3,236,844 0.03 11.19 9,288 36,220,284
2023-10-10 2023-10-06 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 250 3,236,014 0.01 11.27 2,818 36,469,878
2023-10-06 2023-10-05 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 1,400 3,235,764 0.04 11.09 15,526 35,884,623
2023-10-06 2023-10-04 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 1,820 3,234,364 0.06 10.95 19,929 35,416,286
2023-08-16 2023-08-16 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 115 3,232,544 0.00 15.15 1,742 48,973,042
2023-08-16 2023-08-15 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 235 3,232,429 0.01 14.34 3,370 46,353,032
2023-08-11 2023-08-11 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 180 3,232,194 0.01 14.66 2,639 47,383,964
2023-08-11 2023-08-08 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 120 3,232,014 0.00 14.83 1,780 47,930,768
2023-07-24 2023-07-21 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 225 3,231,894 0.01 14.85 3,341 47,993,626
2023-07-24 2023-07-20 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 110 3,231,669 0.00 15.06 1,657 48,668,935
2023-07-20 2023-07-19 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 200 3,231,559 0.01 14.33 2,866 46,308,240
2023-07-18 2023-07-14 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 150 3,231,359 0.00 15.03 2,254 48,567,326
2023-07-18 2023-07-07 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 110 3,231,209 0.00 16.19 1,781 52,313,274
2023-07-07 2023-07-06 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 320 3,231,099 0.01 14.88 4,762 48,078,753
2023-06-27 2023-06-26 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 750 3,230,779 0.02 16.50 12,375 53,307,854
2023-06-22 2023-06-21 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 500 3,230,029 0.02 17.88 8,940 57,752,919
2023-06-08 2023-06-08 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 120 3,229,529 0.00 17.53 2,104 56,613,643
2023-06-08 2023-06-07 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 230 3,229,409 0.01 17.41 4,004 56,224,011
2023-06-01 2023-05-31 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 330 3,229,179 0.01 17.28 5,702 55,800,213
2023-05-26 2023-05-24 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 200 3,228,849 0.01 17.49 3,498 56,472,569
2023-05-18 2023-05-16 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 320 3,228,649 0.01 17.02 5,448 54,967,749
2023-03-27 2023-03-23 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 230 3,228,329 0.01 12.13 2,790 39,159,631
2023-03-23 2023-03-21 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 480 3,228,099 0.01 12.08 5,798 38,995,436
2023-03-21 2023-03-20 4 XAIR Beyond Air, Inc.
Common Stock 		P - Purchase 2,300 144,736 1.61 6.48 14,904 937,889
2023-03-16 2023-03-15 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 480 3,227,619 0.01 10.91 5,237 35,213,323
2023-03-16 2023-03-14 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 1,680 3,227,139 0.05 10.85 18,228 35,014,458
2023-01-13 2023-01-12 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		A - Award 210,000 3,225,459 6.96
2022-11-30 2022-11-30 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 150 3,015,459 0.00 7.45 1,118 22,465,170
2022-11-29 2022-11-29 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 150 3,015,309 0.00 7.45 1,118 22,464,052
2022-11-29 2022-11-28 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 150 3,015,159 0.00 7.40 1,110 22,312,177
2022-11-29 2022-11-25 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 150 3,015,009 0.00 7.38 1,107 22,250,766
2022-11-21 2022-11-18 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 500 3,014,859 0.02 7.23 3,615 21,797,431
2022-11-21 2022-11-17 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 250 3,014,359 0.01 7.24 1,810 21,823,959
2022-11-16 2022-11-10 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 1,000 3,014,109 0.03 7.07 7,070 21,309,751
2022-10-03 2022-09-30 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 500 3,013,109 0.02 7.46 3,730 22,477,793
2022-10-03 2022-09-28 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 500 3,012,609 0.02 7.23 3,615 21,781,163
2022-09-27 2022-09-26 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 500 3,012,109 0.02 7.69 3,845 23,163,118
2022-09-27 2022-09-23 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 1,000 3,011,609 0.03 7.93 7,930 23,882,059
2022-09-06 2022-09-02 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 1,200 3,010,609 0.04 8.37 10,044 25,198,797
2022-09-06 2022-09-01 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 500 3,009,409 0.02 8.11 4,055 24,406,307
2022-08-30 2022-08-29 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 1,000 3,008,909 0.03 9.07 9,070 27,290,805
2022-08-30 2022-08-23 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 500 3,007,909 0.02 9.00 4,500 27,071,181
2022-08-22 2022-08-19 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 5,000 3,007,409 0.17 8.99 44,950 27,036,607
2022-08-22 2022-08-18 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 14,426 3,002,409 0.48 8.58 123,775 25,760,669
2022-08-16 2022-08-11 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 19,669 2,987,983 0.66 8.40 165,220 25,099,057
2022-07-05 2022-06-30 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale -40,000 142,436 -21.93 6.53 -261,104 929,765
2022-06-30 2022-06-29 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 3,700 2,968,314 0.12 11.62 42,994 34,491,809
2022-06-30 2022-06-28 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 300 2,964,614 0.01 11.82 3,546 35,041,737
2022-06-27 2022-06-24 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 400 2,964,314 0.01 12.18 4,872 36,105,345
2022-06-27 2022-06-23 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 200 2,963,914 0.01 11.40 2,280 33,788,620
2022-06-27 2022-06-22 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 100 2,963,714 0.00 13.10 1,310 38,824,653
2022-05-31 2022-05-27 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 500 2,963,614 0.02 15.74 7,870 46,647,284
2022-05-31 2022-05-26 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 500 2,963,114 0.02 15.90 7,950 47,113,513
2022-05-23 2022-05-20 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 1,000 2,962,614 0.03 16.28 16,280 48,231,356
2022-05-23 2022-05-19 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 200 2,961,614 0.01 18.95 3,790 56,122,585
2022-05-19 2022-05-18 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 1,000 2,961,414 0.03 18.49 18,490 54,756,545
2022-05-19 2022-05-18 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 700 2,960,414 0.02 20.60 14,420 60,984,528
2022-05-19 2022-05-17 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 110 2,959,714 0.00 20.83 2,291 61,650,843
2022-05-19 2022-05-17 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 200 2,959,604 0.01 19.77 3,954 58,511,371
2022-05-17 2022-05-16 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 1,000 2,959,404 0.03 19.32 19,320 57,175,685
2022-05-17 2022-05-13 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 700 2,958,404 0.02 18.10 12,670 53,547,112
2022-05-13 2022-05-12 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 10,545 2,957,704 0.36 17.26 182,007 51,049,971
2022-05-13 2022-05-12 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 600 2,947,159 0.02 16.12 9,672 47,508,203
2022-05-13 2022-05-12 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		P - Purchase 1,100 2,946,559 0.04 14.88 16,368 43,844,798
2022-04-05 2022-04-01 4 NVCT Nuvectis Pharma, Inc.
Common Stock 		A - Award 120,000 2,945,459 4.25
2022-03-29 2022-03-28 4 NVCT Nuvectis Pharma, Inc.
Common Stock, par value $0.00001 		P - Purchase 4,000 2,825,459 0.14 7.05 28,200 19,919,486
2022-03-18 2022-03-17 4 NVCT Nuvectis Pharma, Inc.
Common Stock, par value $0.00001 		P - Purchase 7,000 2,821,459 0.25 7.63 53,410 21,527,732
2022-03-07 2022-03-03 4 XAIR Beyond Air, Inc.
Stock Option (right to buy) 		A - Award 30,000 30,000
2022-02-15 2022-02-14 4 NVCT Nuvectis Pharma, Inc.
Common Stock, par value $0.00001 		P - Purchase 8,000 2,814,459 0.29 5.88 47,040 16,549,019
2022-02-11 2022-02-10 4 NVCT Nuvectis Pharma, Inc.
Common Stock, par value $0.00001 		P - Purchase 8,500 2,806,459 0.30 6.34 53,890 17,792,950
2022-02-08 3 NVCT Nuvectis Pharma, Inc.
Common Stock 		2,565,459
2022-02-08 2022-02-07 4 NVCT Nuvectis Pharma, Inc.
Common Stock, par value $0.00001 		P - Purchase 6,000 2,797,959 0.21 8.25 49,500 23,083,162
2022-02-08 2022-02-07 4 NVCT Nuvectis Pharma, Inc.
Common Stock, par value $0.00001 		P - Purchase 14,000 2,791,959 0.50 3.93 55,020 10,972,399
2022-02-08 2022-02-04 4 NVCT Nuvectis Pharma, Inc.
Common Stock, par value $0.00001 		P - Purchase 12,500 2,777,959 0.45 3.89 48,625 10,806,261
2022-02-08 2022-02-04 4 NVCT Nuvectis Pharma, Inc.
Common Stock, par value $0.00001 		P - Purchase 200,000 2,765,459 7.80 5.00 1,000,000 13,827,295
2021-11-26 2021-11-24 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale -6,464 182,436 -3.42 13.99 -90,431 2,552,280
2021-11-26 2021-11-24 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale -31,000 188,900 -14.10 13.44 -416,640 2,538,816
2021-11-24 2021-11-22 4 XAIR Beyond Air, Inc.
Warrants (right to buy) 		M - Exercise -50,000 0 -100.00
2021-11-24 2021-11-22 4 XAIR Beyond Air, Inc.
Common Stock 		F - Taxes -12,536 219,900 -5.39 14.60 -182,988 3,209,880
2021-11-24 2021-11-22 4 XAIR Beyond Air, Inc.
Common Stock 		M - Exercise 50,000 232,436 27.41 3.66 183,000 850,716
2021-03-08 2021-03-04 4 XAIR Beyond Air, Inc.
Stock Option (right to buy) 		A - Award 25,000 25,000
2021-02-18 2021-02-12 4 XAIR Beyond Air, Inc.
Tranche B Warrant (Right to Buy) 		M - Exercise -23,419 0 -100.00
2021-02-18 2021-02-12 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale -23,419 182,436 -11.38 6.36 -148,945 1,160,293
2021-02-18 2021-02-12 4 XAIR Beyond Air, Inc.
Common Stock 		M - Exercise 23,419 205,855 12.84 4.25 99,531 874,884
2021-02-18 2021-02-11 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale -1,500 182,436 -0.82 6.28 -9,420 1,145,698
2021-02-08 2021-01-02 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale -5,700 183,936 -3.01 5.89 -33,573 1,083,383
2020-08-27 2020-08-25 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale X -1,580 189,636 -0.83 5.95 -9,406 1,128,960
2020-08-25 2020-08-24 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale X -3,889 191,216 -1.99 5.68 -22,104 1,086,834
2020-08-25 2020-08-21 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale X -3,246 195,105 -1.64 6.05 -19,651 1,181,127
2020-08-21 2020-08-20 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale X -3,778 198,351 -1.87 6.29 -23,780 1,248,481
2020-08-21 2020-08-19 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale X -6,533 202,129 -3.13 6.32 -41,266 1,276,748
2020-08-19 2020-08-18 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale X -4,578 208,662 -2.15 5.83 -26,691 1,216,562
2020-08-18 2020-08-17 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale X -4,413 213,240 -2.03 5.72 -25,226 1,218,944
2020-08-17 2020-08-14 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale X -6,680 217,653 -2.98 5.53 -36,932 1,203,338
2020-08-14 2020-08-13 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale X -4,088 224,333 -1.79 5.50 -22,494 1,234,392
2020-08-13 2020-08-12 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale X -4,689 228,421 -2.01 5.30 -24,834 1,209,786
2020-08-12 2020-07-27 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale X -4,917 278,582 -1.73 6.27 -30,807 1,745,428
2020-08-12 2020-08-11 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale X -3,910 233,110 -1.65 5.51 -21,553 1,284,949
2020-08-12 2020-08-10 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale X -3,437 237,020 -1.43 5.42 -18,636 1,285,146
2020-08-10 2020-08-07 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale X -10,222 245,374 -4.00 5.35 -54,657 1,312,015
2020-08-07 2020-08-06 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale X -6,192 255,596 -2.37 5.94 -36,777 1,518,112
2020-08-07 2020-08-05 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale X -3,619 261,788 -1.36 6.16 -22,286 1,612,117
2020-08-06 2020-08-04 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale X -3,649 265,407 -1.36 6.13 -22,369 1,627,025
2020-08-04 2020-08-03 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale X -3,814 269,056 -1.40 6.16 -23,489 1,656,981
2020-08-04 2020-07-31 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale X -2,868 272,870 -1.04 6.27 -17,970 1,709,694
2020-07-31 2020-07-30 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale X -3,418 275,738 -1.22 6.26 -21,404 1,726,699
2020-07-31 2020-07-29 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale X -1,827 279,156 -0.65 6.09 -11,135 1,701,400
2020-07-31 2020-07-29 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale X -2,516 280,983 -0.89 6.20 -15,596 1,741,757
2020-06-10 2020-06-10 4 STML STEMLINE THERAPEUTICS INC
Stock Option (right to buy) 		D - Sale to Issuer -24,000 0 -100.00
2020-06-10 2020-06-10 4 STML STEMLINE THERAPEUTICS INC
Stock Option (right to buy) 		D - Sale to Issuer -34,000 0 -100.00
2020-06-10 2020-06-10 4 STML STEMLINE THERAPEUTICS INC
Stock Option (right to buy) 		D - Sale to Issuer -18,070 0 -100.00
2020-06-10 2020-06-10 4 STML STEMLINE THERAPEUTICS INC
Stock Option (right to buy) 		D - Sale to Issuer -9,034 0 -100.00
2020-06-10 2020-06-10 4 STML STEMLINE THERAPEUTICS INC
Common Stock 		U - Other -66,346 0 -100.00
2019-06-28 2019-06-25 4 STML STEMLINE THERAPEUTICS INC
Common Stock 		A - Award 10,000 65,443 18.04
2019-06-28 2019-06-25 4 STML STEMLINE THERAPEUTICS INC
Common Stock 		A - Award 15,000 55,443 37.09
2019-01-10 3 URGN UroGen Pharma Ltd.
Ordinary Shares 		76,226
2019-01-10 3 URGN UroGen Pharma Ltd.
Ordinary Shares 		76,226
2019-01-10 3 URGN UroGen Pharma Ltd.
Ordinary Shares 		76,226
2018-06-22 2018-06-21 4 STML STEMLINE THERAPEUTICS INC
Common Stock 		A - Award 13,158 40,443 48.22
2018-05-15 2018-02-16 4 AITB AIT Therapeutics, Inc.
Tranche A Warrant (right to buy) 		M - Exercise -23,419 0 -100.00
2018-05-15 2018-02-16 4 AITB AIT Therapeutics, Inc.
Tranche A Warrant (right to buy) 		P - Purchase 23,419 23,419 0.01 234 234
2018-05-15 2018-02-16 4 AITB AIT Therapeutics, Inc.
Tranche B Warrant (right to buy) 		P - Purchase 23,419 23,419 0.01 234 234
2018-05-15 2018-02-16 4 AITB AIT Therapeutics, Inc.
Common Stock 		M - Exercise 23,419 283,499 9.00 4.25 99,531 1,204,871
2017-06-20 2017-06-19 4 STML STEMLINE THERAPEUTICS INC
Stock Options (right to buy) 		A - Award 24,000 24,000
2017-06-20 2017-06-19 4 STML STEMLINE THERAPEUTICS INC
Common Stock 		A - Award 10,000 27,285 57.85
2017-06-20 3 AITB AIT Therapeutics, Inc.
Common Stock 		520,158
2017-06-20 3 AITB AIT Therapeutics, Inc.
Common Stock 		520,158
2016-05-26 2016-05-25 4 STML STEMLINE THERAPEUTICS INC
Stock Options (right to buy) 		A - Award 34,000 34,000
2015-06-25 2015-06-23 4 STML STEMLINE THERAPEUTICS INC
Stock Options (right to buy) 		A - Award 24,000 24,000
2015-06-25 2015-06-23 4 STML STEMLINE THERAPEUTICS INC
Common Stock 		A - Award 10,000 17,285 137.27
2015-04-08 2015-04-06 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		S - Sale -1,592 777,209 -0.20 11.68 -18,595 9,077,801
2015-03-20 2015-03-18 4 STML STEMLINE THERAPEUTICS INC
Stock Options (right to buy) 		M - Exercise -5,421 0 -100.00
2015-03-20 2015-03-18 4 STML STEMLINE THERAPEUTICS INC
Common Stock 		S - Sale -1,388 7,285 -16.00 16.12 -22,375 117,434
2015-03-20 2015-03-18 4 STML STEMLINE THERAPEUTICS INC
Common Stock 		M - Exercise 5,421 8,673 166.70 4.09 22,172 35,473
2015-01-06 2015-01-05 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		S - Sale -5,574 778,801 -0.71 13.79 -76,865 10,739,666
2015-01-06 2015-01-04 4 KERX KERYX BIOPHARMACEUTICALS INC
Employee Stock Option (Right to Buy) 		A - Award 134,750 134,750
2015-01-06 2015-01-04 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		A - Award 67,375 784,375 9.40
2015-01-02 2014-12-30 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		S - Sale -200,000 717,000 -21.81 14.11 -2,822,000 10,116,870
2014-12-29 2014-12-29 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		S - Sale -87,988 917,000 -8.76 13.98 -1,230,072 12,819,660
2014-12-29 2014-12-26 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		S - Sale -63,500 1,004,988 -5.94 13.98 -887,730 14,049,732
2014-12-29 2014-12-24 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		S - Sale -83,000 1,068,488 -7.21 13.98 -1,160,340 14,937,462
2014-12-29 2014-12-23 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		S - Sale -104,489 1,151,488 -8.32 13.98 -1,460,756 16,097,802
2014-12-23 2014-12-22 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		A - Award 500,000 1,255,977 66.14
2014-10-07 2014-10-06 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		S - Sale -68,800 755,977 -8.34 15.87 -1,091,856 11,997,355
2014-10-07 2014-10-03 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		S - Sale -2,038 824,777 -0.25 16.14 -32,893 13,311,901
2014-09-12 2014-09-12 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		S - Sale -50,000 826,815 -5.70 14.24 -712,000 11,773,846
2014-07-09 2014-07-07 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		S - Sale -1,788 876,815 -0.20 15.75 -28,161 13,809,836
2014-06-23 2014-06-19 4 STML STEMLINE THERAPEUTICS INC
Stock Options (right to buy) 		A - Award 20,000 20,000
2014-04-07 2014-04-03 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		S - Sale -1,816 878,603 -0.21 16.46 -29,891 14,461,805
2014-01-06 2014-01-03 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		S - Sale -5,257 880,419 -0.59 12.57 -66,080 11,066,867
2014-01-06 2014-01-02 4 KERX KERYX BIOPHARMACEUTICALS INC
Employee Stock Option (Right to Buy) 		A - Award 62,092 62,092
2014-01-06 2014-01-02 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		A - Award 26,611 885,676 3.10
2013-10-08 2013-10-04 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		A - Award 400,000 859,065 87.13
2013-10-07 2013-10-03 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		S - Sale -2,505 459,065 -0.54 10.25 -25,676 4,705,416
2013-07-09 2013-07-05 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		S - Sale -2,440 461,570 -0.53 7.95 -19,398 3,669,482
2013-06-21 2013-06-19 4 STML STEMLINE THERAPEUTICS INC
Stock Options (right to buy) 		A - Award 20,000 20,000
2013-04-08 2013-04-05 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		S - Sale -1,795 464,010 -0.39 6.93 -12,439 3,215,589
2013-03-29 2013-03-27 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		S - Sale -31,231 465,805 -6.28 6.88 -214,869 3,204,738
2013-01-28 3 STML STEMLINE THERAPEUTICS INC
Common Stock 		3,252
2013-01-04 2013-01-04 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		S - Sale -6,010 497,036 -1.19 2.74 -16,467 1,361,879
2013-01-04 2013-01-02 4 KERX KERYX BIOPHARMACEUTICALS INC
Employee Stock Option (right to buy) 		A - Award 75,000 75,000
2013-01-04 2013-01-02 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		A - Award 25,000 503,046 5.23
2012-10-05 2012-10-03 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		S - Sale -746 478,046 -0.16 2.72 -2,029 1,300,285
2012-07-06 2012-07-03 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		S - Sale -684 478,792 -0.14 1.99 -1,361 952,796
2012-04-19 2012-04-18 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		P - Purchase 3,800 479,476 0.80 1.28 4,883 616,127
2012-04-19 2012-04-18 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		P - Purchase 15,300 475,676 3.32 1.30 19,890 618,379
2012-04-04 2012-04-04 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		P - Purchase 71,400 460,376 18.36 1.38 98,525 635,273
2012-01-03 2012-01-03 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		S - Sale -3,305 388,976 -0.84 2.62 -8,676 1,021,062
2012-01-03 2012-01-02 4 KERX KERYX BIOPHARMACEUTICALS INC
Employee Stock Options (Right to Buy) 		A - Award 67,000 67,000
2012-01-03 2012-01-02 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock 		A - Award 33,000 392,281 9.19
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券（例如期權）
V
內部人士透過Form 4自願報告的一筆交易
J
其他（附有交易描述的腳註）